There aren't any trials of BENICAR HCT demonstrating reductions in cardiovascular hazard in clients with hypertension, but at least just one drug pharmacologically comparable to olmesartan medoxomil has shown these kinds of Rewards, and hydrochlorothiazide shown reduction of cardiovascular c